The Oncologic Drugs Advisory Committee (ODAC) receives requests for technical and clinical evaluation of new drugs by the U.S. Food and Drug Administration (FDA).
The Oncologic Drugs Advisory Committee (ODAC), under the oversight of the U.S. Food and Drug Administration (FDA), receives inquiries regarding the technical and clinical evaluation of new drugs.